HSP90AB1 and colon adenocarcinoma: Here, we performed SEC-MS to characterize global changes to native protein complex distributions upon HSP90 inhibition with the geldanamycin-derivative tanespimycin (17-AAG) in the HT29 human colon adenocarcinoma cell line.